SHL Telemedicine (NASDAQ:SHLT) Stock Price Down 4.7% – Should You Sell?

SHL Telemedicine Ltd. (NASDAQ:SHLT)’s share price traded down 4.7% on Thursday . The stock traded as low as $2.30 and last traded at $2.38. 6,563 shares changed hands during trading, a decline of 31% from the average session volume of 9,511 shares. The stock had previously closed at $2.50.

SHL Telemedicine Trading Down 4.7 %

The company has a current ratio of 2.17, a quick ratio of 1.98 and a debt-to-equity ratio of 0.19. The firm’s 50-day moving average price is $2.54 and its two-hundred day moving average price is $2.86.

Institutional Trading of SHL Telemedicine

A hedge fund recently bought a new stake in SHL Telemedicine stock. Sphera Management Technology Funds Ltd purchased a new stake in shares of SHL Telemedicine Ltd. (NASDAQ:SHLT) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 32,642 shares of the company’s stock, valued at approximately $87,000. Sphera Management Technology Funds Ltd owned about 0.20% of SHL Telemedicine as of its most recent SEC filing. Hedge funds and other institutional investors own 20.11% of the company’s stock.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.